1. Home
  2. HRMY vs GBX Comparison

HRMY vs GBX Comparison

Compare HRMY & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • GBX
  • Stock Information
  • Founded
  • HRMY 2017
  • GBX 1974
  • Country
  • HRMY United States
  • GBX United States
  • Employees
  • HRMY N/A
  • GBX N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • GBX Railroads
  • Sector
  • HRMY Health Care
  • GBX Industrials
  • Exchange
  • HRMY Nasdaq
  • GBX Nasdaq
  • Market Cap
  • HRMY 2.0B
  • GBX 1.9B
  • IPO Year
  • HRMY 2020
  • GBX N/A
  • Fundamental
  • Price
  • HRMY $39.05
  • GBX $66.85
  • Analyst Decision
  • HRMY Strong Buy
  • GBX Hold
  • Analyst Count
  • HRMY 8
  • GBX 3
  • Target Price
  • HRMY $55.00
  • GBX $64.00
  • AVG Volume (30 Days)
  • HRMY 593.9K
  • GBX 396.1K
  • Earning Date
  • HRMY 02-20-2025
  • GBX 01-08-2025
  • Dividend Yield
  • HRMY N/A
  • GBX 1.79%
  • EPS Growth
  • HRMY N/A
  • GBX 73.07
  • EPS
  • HRMY 2.11
  • GBX 5.73
  • Revenue
  • HRMY $681,879,000.00
  • GBX $3,611,800,000.00
  • Revenue This Year
  • HRMY $24.79
  • GBX $0.97
  • Revenue Next Year
  • HRMY $19.00
  • GBX $1.51
  • P/E Ratio
  • HRMY $18.55
  • GBX $11.67
  • Revenue Growth
  • HRMY 25.83
  • GBX N/A
  • 52 Week Low
  • HRMY $28.14
  • GBX $41.40
  • 52 Week High
  • HRMY $41.61
  • GBX $69.12
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 71.30
  • GBX 63.02
  • Support Level
  • HRMY $35.72
  • GBX $65.86
  • Resistance Level
  • HRMY $37.16
  • GBX $67.77
  • Average True Range (ATR)
  • HRMY 1.29
  • GBX 1.84
  • MACD
  • HRMY 0.48
  • GBX 0.66
  • Stochastic Oscillator
  • HRMY 92.25
  • GBX 89.79

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: